Basic and Clinical Reproductive Sciences is an elite, highly cited, scientific open access journal that publishes peer reviewed, original research and review articles in the field of Reproductive science and medicine. The Journal aims to render a global platform for scientists and academicians to discuss and share numerous developments and issues related to Reproductive science. The journal provides multi-disciplinary interpretation of the latest research advances in different aspects of basic and clinical reproductive science and medicine, including basic reproductive biology, maternal-foetal medicine, obstetrics, gynaecology, gestation, reproductive endocrinology, uro-gynaecology, and embryology as research articles, review articles, short communications, short reports, book reviews, and letter to editor focussed on contemporary topics of reproductive medicine.

We are sharing one of the most cited article from our journal. Article entitled “An Overview of Vulvovaginal Atrophy‑Related Sexual Dysfunction in Postmenopausal Women” well written by Dr. Tochukwu Christopher Okeke.

Abstract

Menopause and the climacteric period are associated with adverse risk factors for the development of vulvovaginal atrophy‑related sexual dysfunction. Sexual dysfunction is a common problem in postmenopausal women, often underdiagnosed, inadequately treated, frequently overlooked, and most often impairing the quality of life of these women. To provide clinicians with current information on vulvovaginal atrophy‑related sexual dysfunction in postmenopausal women. This study is a literature review on vulvovaginal atrophy‑related sexual dysfunction in postmenopausal women. Relevant publications were identified through a search of PubMed and Medline, selected references, journals, and textbooks on this topic, and were included in the review. The prevalence of female sexual dysfunction increases with age. It is a common multidimensional problem for postmenopausal women that alter the physiological, biochemical, psychological, and sociocultural environment of a woman. Menopause‑related sexual dysfunction may not be reversible without therapy. Estrogen therapy is the most effective option and is the current standard of care for vulvovaginal atrophy‑related sexual dysfunction in postmenopausal women. Sexual dysfunction is a common multidimensional problem for postmenopausal women and often impairs the quality of life of these women. Estrogen preparations are the most effective treatment. Selective estrogen receptor modulators, vaginal dehydroepiandrostenedione, vaginal testosterone, and tissue‑selective estrogen complexes are promising therapies, but further studies are required to confirm their role, efficacy, and safety.

Here is the link to view complete article: https://www.jbcrs.org/articles/an-overview-of-vulvovaginal-atrophyrelated-sexual-dysfunction-in-postmenopausal-women.pdf

Authors are welcome to submit their manuscripts. Submit manuscript at https://www.scholarscentral.org/submissions/basic-clinical-reproductive-sciences.htmlhttps://www.scholarscentral.org/submissions/basic-clinical-reproductive-sciences.html (or) as an e-mail attachment to reproductivesci@emedsci.com

Media contact

Eliza Grace

Managing Editor

Journal of Basic and Clinical Reproductive Sciences